{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T10:43:58Z","timestamp":1779360238100,"version":"3.51.4"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Parasitology"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.exppara.2018.10.003","type":"journal-article","created":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T16:15:40Z","timestamp":1539706540000},"page":"44-53","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Could Araucaria heterophylla resin extract be used as a new treatment for toxoplasmosis?"],"prefix":"10.1016","volume":"195","author":[{"given":"Nora L.","family":"El-Tantawy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amal F.","family":"Soliman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aida","family":"Abdel-Magied","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doaa","family":"Ghorab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashraf T.","family":"Khalil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zein M.","family":"Naeem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuniyoshi","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saleh H.","family":"El-Sharkawy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.exppara.2018.10.003_bib1","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1515\/znc-2009-11-1211","article-title":"Chemical and biological investigation of Araucaria heterophylla Salisb. Resin","volume":"64","author":"Abdel-Sattar","year":"2009","journal-title":"Z. Naturforsch."},{"key":"10.1016\/j.exppara.2018.10.003_bib2","first-page":"1","article-title":"The histopathological picture of concomitant infection with Leishmania major and Toxoplasma gondii in albino mice","author":"Abdel Wahab","year":"1989","journal-title":"J. Egypt. Soc. Parasitol."},{"issue":"1","key":"10.1016\/j.exppara.2018.10.003_bib3","first-page":"43","article-title":"Anti-toxoplasmosis activity of herbal medicines: narrative review","volume":"2","author":"Arab-Mazar","year":"2017","journal-title":"Herbal Medicines Journal"},{"key":"10.1016\/j.exppara.2018.10.003_bib4","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1007\/BF01690096","article-title":"Use of rifabutin in combination with atovaquone, clindamycin, pyrimethamine, or sulfadiazine for treatment of toxoplasmic encephalitis in mice","volume":"15","author":"Araujo","year":"1996","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"issue":"1\u20132","key":"10.1016\/j.exppara.2018.10.003_bib5","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.vetpar.2011.12.039","article-title":"Enrofloxacin is able to control Toxoplasma gondii infection in both in vitro and in vivo experimental models","volume":"8","author":"Barbosa","year":"2012","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.exppara.2018.10.003_bib6","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1097\/00000478-199512000-00007","article-title":"Chronic hepatitis. An update on terminology and reporting","volume":"19","author":"Batts","year":"1995","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.exppara.2018.10.003_bib7","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0031-9422(00)91236-6","article-title":"New diterpenes from Araucaria cunninghami","volume":"13","author":"Caputo","year":"1974","journal-title":"Phytochemistry"},{"key":"10.1016\/j.exppara.2018.10.003_bib8","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0031-9422(00)91234-2","article-title":"Diterpenes from Araucaria bidwilli","volume":"13","author":"Caputo","year":"1974","journal-title":"Phytochemistry"},{"issue":"3","key":"10.1016\/j.exppara.2018.10.003_bib9","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.exppara.2009.04.010","article-title":"Toxoplasma gondii: effects of Artemisia annua L. on susceptibility to infection in experimental models in vitro and in vivo","volume":"122","author":"De Oliveira","year":"2009","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.exppara.2018.10.003_bib10","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.exppara.2015.06.009","article-title":"Nitric oxide production increases Toxoplasma gondii encephalitis in mice","volume":"156","author":"Dincel","year":"2015","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.exppara.2018.10.003_bib11","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1177\/0394632016638668","article-title":"Role of oxidative stress in the pathophysiology of Toxoplasma gondii infection","volume":"29","author":"Dincel","year":"2016","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"10.1016\/j.exppara.2018.10.003_bib12","first-page":"99","article-title":"Murine model of drug-induced reactivation of Toxoplasma gondii","volume":"40","author":"Djakovic","year":"2001","journal-title":"Acta Protozool."},{"key":"10.1016\/j.exppara.2018.10.003_bib13","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s00281-012-0339-3","article-title":"Immune response and immunopathology during toxoplasmosis","volume":"34","author":"Dupont","year":"2012","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.exppara.2018.10.003_bib14","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.exppara.2012.05.001","article-title":"Initial characterization of an autoclaved Toxoplasma vaccine in mice","volume":"131","author":"Eissa","year":"2012","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.exppara.2018.10.003_bib15","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.exppara.2015.06.005","article-title":"Could miltefosine be used as a therapy for toxoplasmosis?","volume":"157","author":"Eissa","year":"2015","journal-title":"Exp. Parasitol."},{"issue":"1","key":"10.1016\/j.exppara.2018.10.003_bib16","first-page":"185","article-title":"Effect of artesunate on Toxoplasma gondii: in vitro and in vivo studies","volume":"38","author":"El Zawawy","year":"2008","journal-title":"J. Egypt. Soc. Parasitol."},{"key":"10.1016\/j.exppara.2018.10.003_bib17","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.exppara.2014.12.007","article-title":"Triclosan and triclosan-loaded liposomal nanoparticles in the treatment of acute experimental toxoplasmosis","volume":"149","author":"El-Zawawy","year":"2015","journal-title":"Exp. Parasitol."},{"issue":"5","key":"10.1016\/j.exppara.2018.10.003_bib1a","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1590\/S0102-695X2012005000045","article-title":"Investigation of antioxidant and anti-glycation properties of essential oils from fruits and branchlets of Juniperus oblonga","volume":"22","author":"Emami","year":"2012","journal-title":"Rev. Bras. Farmacogn."},{"issue":"11","key":"10.1016\/j.exppara.2018.10.003_bib18","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1590\/0074-02760170045","article-title":"Histopathology of murine toxoplasmosis under treatment with dialyzable leukocyte extract","volume":"112","author":"Fuentes-Castro","year":"2017","journal-title":"Mem. Inst. Oswaldo Cruz"},{"issue":"3","key":"10.1016\/j.exppara.2018.10.003_bib19","doi-asserted-by":"crossref","first-page":"281","DOI":"10.4103\/0974-777X.83536","article-title":"Toxoplasmosis: a global threat","volume":"3","author":"Furtado","year":"2011","journal-title":"J. Global Infect. Dis."},{"key":"10.1016\/j.exppara.2018.10.003_bib20","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.exppara.2014.05.005","article-title":"Chitosan and silver nanoparticles: promising anti-Toxoplasma agents","volume":"143","author":"Gaafar","year":"2014","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.exppara.2018.10.003_bib21","first-page":"499","article-title":"Nonclinical vehicle use in studies by multiple routes in multipler","volume":"25","author":"Gad","year":"2006","journal-title":"Int. J. Technoethics (IJT)"},{"key":"10.1016\/j.exppara.2018.10.003_bib22","series-title":"Principles and Techniques of Electron Microscopy: Biological Applications","author":"Hayat","year":"2000"},{"key":"10.1016\/j.exppara.2018.10.003_bib24","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1186\/1756-3305-7-248","article-title":"Starvation of low-density lipoprotein-derived cholesterol induces bradyzoite conversion in Toxoplasma gondii","volume":"7","author":"Ihara","year":"2014","journal-title":"Parasites Vectors"},{"key":"10.1016\/j.exppara.2018.10.003_bib25","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1586\/erv.10.113","article-title":"Vaccination against Toxoplasma gondii: an increasing priority for collaborative research?","volume":"9","author":"Innes","year":"2010","journal-title":"Expert Rev. Vaccines"},{"issue":"10","key":"10.1016\/j.exppara.2018.10.003_bib26","doi-asserted-by":"crossref","first-page":"3999","DOI":"10.1007\/s00436-016-5167-2","article-title":"Effects of extracts from Echinacea purpurea (L) MOENCH on mice infected with different strains of Toxoplasma gondii","volume":"115","author":"Junior","year":"2016","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.exppara.2018.10.003_bib27","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.pedhc.2010.04.008","article-title":"Toxoplasmosis: diagnosis, treatment, and prevention in congenitally exposed infants","volume":"25","author":"Kaye","year":"2011","journal-title":"J. Pediatr. Health Care"},{"key":"10.1016\/j.exppara.2018.10.003_bib28","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/1472-6882-12-91","article-title":"In vitro anti-Toxoplasma gondii activity of root extract\/fractions of Eurycoma longifolia jack","volume":"12","author":"Kavitha","year":"2012","journal-title":"BMC Complement Altern. Med."},{"key":"10.1016\/j.exppara.2018.10.003_bib29","doi-asserted-by":"crossref","first-page":"13955","DOI":"10.1073\/pnas.94.25.13955","article-title":"A dichotomous role for nitric oxide during acute Toxoplasma gondii infection in mice","volume":"94","author":"Khan","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.exppara.2018.10.003_bib30","first-page":"11","article-title":"The cytotoxic and antileishmanial effects of satureja khuzestanica essential oil","volume":"1","author":"Kheirandish","year":"2016","journal-title":"Herbal Med. J."},{"key":"10.1016\/j.exppara.2018.10.003_bib31","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.ijpara.2003.12.009","article-title":"Toxoplasma gondii: the model apicomplexan","volume":"34","author":"Kim","year":"2004","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.exppara.2018.10.003_bib32","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s00436-006-0306-9","article-title":"Subversion of innate and adaptative immune responses by Toxoplasma gondii","volume":"100","author":"Lang","year":"2007","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.exppara.2018.10.003_bib33","series-title":"Plant Resins: Chemistry, Evolution, Ecology, and Ethnobotany","author":"Langenheim","year":"2003"},{"key":"10.1016\/j.exppara.2018.10.003_bib34","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.4049\/jimmunol.140.5.1632","article-title":"Subcutaneous and intestinal vaccination with tachyzoites of Toxoplasma gondii and acquisition of immunity to per oral and congenital Toxoplasma challenge","volume":"140","author":"Mcleod","year":"1988","journal-title":"J. Immunol."},{"key":"10.1016\/j.exppara.2018.10.003_bib35","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s40124-014-0055-7","article-title":"Management of congenital toxoplasmosis","volume":"2","author":"McLeod","year":"2014","journal-title":"Curr. Pediatr. Rep."},{"key":"10.1016\/j.exppara.2018.10.003_bib36","first-page":"414","article-title":"The determination of nitrite in water","volume":"86","author":"Montgomery","year":"1961","journal-title":"Analyst"},{"issue":"2","key":"10.1016\/j.exppara.2018.10.003_bib37","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/0976-0105.177703","article-title":"A simple practice guide for dose conversion between animals and human","volume":"7","author":"Nair","year":"2016","journal-title":"J. Basic Clin. Pharm."},{"key":"10.1016\/j.exppara.2018.10.003_bib38","series-title":"Committee for the Update of the Guide for the Care and Use of Laboratory Animals (2011) Guide for the Care and Use of Laboratory Animals","author":"National Research Council (US)","year":"2011"},{"key":"10.1016\/j.exppara.2018.10.003_bib39","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ijpara.2007.07.007","article-title":"Impact of foetus and mother on IFN-\u03b3-induced indoleamine 2,3-dioxygenase and inducible nitric oxide synthase expression in murine placenta following Toxoplasma gondii infection","volume":"38","author":"Pfaff","year":"2008","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.exppara.2018.10.003_bib2a","doi-asserted-by":"crossref","first-page":"3512","DOI":"10.4049\/jimmunol.162.6.3512","article-title":"Inhibition of inducible nitric oxide synthase exacerbates chronic cerebraltoxoplasmosis in Toxoplasma gondii-susceptible C57BL\/6 mice but does notreactivate the latent disease in T. gondii-resistant BALB\/c mice","volume":"162","author":"Schluter","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.exppara.2018.10.003_bib40","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.exppara.2010.04.019","article-title":"Toxoplasma gondii: the severity of toxoplasmic encephalitis in C57BL\/6 mice is associated with increased ALCAM and VCAM-1 expression in the central nervous system and higher blood\u2013brain barrier permeability","volume":"126","author":"Silva","year":"2010","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.exppara.2018.10.003_bib41","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1002\/ptr.5194","article-title":"The isolation of antiprotozoal compounds from Libyan propolis","volume":"28","author":"Siheri","year":"2014","journal-title":"J. Phytother. Res."},{"key":"10.1016\/j.exppara.2018.10.003_bib42","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1016\/j.vaccine.2011.01.089","article-title":"Induction of protective Th1 immune responses in mice by vaccination with recombinant T. gondii nucleoside triphosphate hydrolase-II","volume":"29","author":"Tan","year":"2011","journal-title":"Vaccine"}],"container-title":["Experimental Parasitology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014489418302534?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014489418302534?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T01:48:34Z","timestamp":1693964914000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014489418302534"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":43,"alternative-id":["S0014489418302534"],"URL":"https:\/\/doi.org\/10.1016\/j.exppara.2018.10.003","relation":{},"ISSN":["0014-4894"],"issn-type":[{"value":"0014-4894","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Could Araucaria heterophylla resin extract be used as a new treatment for toxoplasmosis?","name":"articletitle","label":"Article Title"},{"value":"Experimental Parasitology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exppara.2018.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}